Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, with reference to the announcement by NHS England of 4 December 2016 for a large scale clinical trial of pre-exposure prophylaxis for HIV prevention, what steps he plans to take to ensure that high risk groups not in regular contact with sexual health and genito-urinary medicine clinics access that trial.

The arrangements for the clinical trial on pre-exposure prophylaxis are being developed between NHS England and Public Health England. Issues around reaching high risk groups and eligibility criteria will be addressed as part of that planning.

NHS England will take steps to monitor the impact of the trial on costs of antiretroviral drugs for post exposure prophylaxis.